Urinary iron excretion in patients with prosthetic heart valves.
D000743:Anemia, Hemolytic / Q000209:etiology*; D001803:Blood Transfusion; D002859:Chromium Isotopes; D003676:Deferoxamine / Q000627:therapeutic use*; D004912:Erythrocytes / Q000378:metabolism*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006400:Hematocrit; D006461:Hemolysis; D006486:Hemosiderosis / Q000209:etiology*; D006801:Humans; D007501:Iron / Q000652:urine*; D007505:Iron-Dextran Complex / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000209:etiology; D007770:L-Lactate Dehydrogenase / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use; D014168:Transferrin / Q000378:metabolism
D002859:Chromium Isotopes; D014168:Transferrin; D007505:Iron-Dextran Complex; D007501:Iron; D007770:L-Lactate Dehydrogenase; D003676:Deferoxamine; D011241:Prednisone